Patients perceptions of Artificial Intelligence in diabetic eye screening
dc.citation.issue | 3 | |
dc.citation.volume | 11 | |
dc.contributor.author | Yap A | |
dc.contributor.author | Wilkinson B | |
dc.contributor.author | Chen E | |
dc.contributor.author | Han L | |
dc.contributor.author | Veghefi E | |
dc.contributor.author | Galloway C | |
dc.contributor.author | Squirrell D | |
dc.date.accessioned | 2024-03-11T19:50:14Z | |
dc.date.accessioned | 2024-07-25T06:33:39Z | |
dc.date.available | 2022-05-01 | |
dc.date.available | 2024-03-11T19:50:14Z | |
dc.date.available | 2024-07-25T06:33:39Z | |
dc.date.issued | 2022-05-01 | |
dc.description.abstract | Purpose: Artificial intelligence (AI) technology is poised to revolutionize modern delivery of health care services. We set to evaluate the patient perspective of AI use in diabetic retinal screening. Design: Survey. Methods: Four hundred thirty-eight patients undergoing diabetic retinal screening across New Zealand participated in a survey about their opinion of AI technology in retinal screening. The survey consisted of 13 questions covering topics of awareness, trust, and receptivity toward AI systems. Results: The mean age was 59 years. The majority of participants identified as New Zealand European (50%), followed by Asian (31%), Pacific Islander (10%), and Maori (5%). Whilst 73% of participants were aware of AI, only 58% have heard of it being implemented in health care. Overall, 78% of respondents were comfortable with AI use in their care, with 53% saying they would trust an AI-assisted screening program as much as a health professional. Despite having a higher awareness of AI, younger participants had lower trust in AI systems. A higher proportion of Maori and Pacific participants indicated a preference toward human-led screening. The main perceived benefits of AI included faster diagnostic speeds and greater accuracy. Conclusions: There is low awareness of clinical AI applications among our participants. Despite this, most are receptive toward the implementation of AI in diabetic eye screening. Overall, there was a strong preference toward continual involvement of clinicians in the screening process. There are key recommendations to enhance the receptivity of the public toward incorporation of AI into retinal screening programs. | |
dc.description.confidential | false | |
dc.edition.edition | May-June 2022 | |
dc.format.pagination | 287-293 | |
dc.identifier.citation | Yap A, Wilkinson B, Chen E, Han L, Veghefi E, Galloway C, Squirrell D. (2022). Patients perceptions of Artificial Intelligence in diabetic eye screening. Asia - Pacific Journal of Ophthalmology. 11. 3. (pp. 287-293). | |
dc.identifier.doi | 10.1097/APO.0000000000000525 | |
dc.identifier.elements-type | journal-article | |
dc.identifier.issn | 2162-0989 | |
dc.identifier.pii | S2162098923007120 | |
dc.identifier.uri | https://mro.massey.ac.nz/handle/10179/70417 | |
dc.language | English | |
dc.publisher | Wolters Kluwer Health, Inc. on behalf of the Asia-Pacific Academy of Ophthalmology | |
dc.publisher.uri | https://www.sciencedirect.com/science/article/pii/S2162098923007120 | |
dc.relation.isPartOf | Asia - Pacific Journal of Ophthalmology | |
dc.rights | (c) The author/s | en |
dc.rights.license | CC BY-NC-ND | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
dc.subject | artificial intelligence | |
dc.subject | diabetic retinopathy | |
dc.subject | diagnostic screening programs | |
dc.subject | patient acceptance of health care | |
dc.title | Patients perceptions of Artificial Intelligence in diabetic eye screening | |
dc.type | Journal article | |
pubs.elements-id | 453395 | |
pubs.organisational-group | Other |
Files
Original bundle
1 - 1 of 1